Short Interest in Solana Company (NASDAQ:HSDT) Expands By 93.6%

Solana Company (NASDAQ:HSDT) saw a large increase in short interest during the month of January. As of January 30th, there was short interest totaling 1,351,342 shares, an increase of 93.6% from the January 15th total of 697,852 shares. Based on an average daily volume of 387,052 shares, the short-interest ratio is presently 3.5 days. Currently, 4.0% of the shares of the company are sold short. Currently, 4.0% of the shares of the company are sold short. Based on an average daily volume of 387,052 shares, the short-interest ratio is presently 3.5 days.

Solana Stock Up 2.4%

Shares of NASDAQ HSDT opened at $1.93 on Friday. The company has a market cap of $79.71 million, a P/E ratio of 0.00 and a beta of 1.06. Solana has a 52 week low of $1.81 and a 52 week high of $449.93. The business has a 50-day simple moving average of $2.96 and a two-hundred day simple moving average of $6.63.

Solana (NASDAQ:HSDT) last announced its quarterly earnings results on Tuesday, November 18th. The company reported ($32.89) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($50.50) by $17.61. The firm had revenue of $0.70 million for the quarter, compared to the consensus estimate of $0.11 million. Solana had a negative net margin of 39,358.88% and a negative return on equity of 699.93%.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. Wall Street Zen raised Solana from a “sell” rating to a “hold” rating in a report on Saturday, November 22nd. Weiss Ratings reiterated a “sell (e+)” rating on shares of Solana in a research note on Thursday, January 22nd. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has an average rating of “Sell”.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Grant Private Wealth Management Inc bought a new stake in Solana during the fourth quarter valued at $46,000. Aristides Capital LLC purchased a new position in shares of Solana during the fourth quarter worth about $137,000. LPL Financial LLC increased its position in shares of Solana by 120.1% in the fourth quarter. LPL Financial LLC now owns 382,255 shares of the company’s stock worth $1,105,000 after purchasing an additional 208,558 shares during the last quarter. Quattro Financial Advisors LLC purchased a new stake in Solana in the fourth quarter valued at approximately $604,000. Finally, Franchise GP Ltd bought a new stake in Solana during the fourth quarter valued at approximately $653,000. Institutional investors own 18.63% of the company’s stock.

About Solana

Helius Medical Technologies, Inc (NASDAQ: HSDT) is a medical technology company focused on developing and commercializing non‐invasive neuromodulation platforms designed to enhance neurorehabilitation. Its flagship product, the Portable Neuromodulation Stimulator (PoNS®), delivers mild electrical pulses to the tongue to stimulate neural pathways in conjunction with targeted physical therapy. The device is intended to improve neuroplasticity and support recovery in patients with neurological conditions.

The PoNS system is cleared for use in the United States, Canada and the European Union and is prescribed through specialized rehabilitation clinics.